Phase IIB TMB High Pan Tumor FA for tTMB
Research payments
$616,122
Through program year 2021, $616,122 in research payments was reported against Phase IIB TMB High Pan Tumor FA for tTMB, across 21 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $266,564 | 9 |
| 2020 | Research | $349,558 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jacqueline Vuky Portland, OR Named on 4 payments
- Kristi McIntyre Dallas, TX Named on 2 payments
- Aung Naing Houston, TX Named on 2 payments
- Jeffrey Yorio Austin, TX Named on 2 payments
- Allen Cohn Denver, CO Named on 2 payments
- Timothy Larson Minneapolis, MN Named on 2 payments
- Donald Richards Tyler, TX Named on 2 payments
- Ronald Harris Binghamton, NY Named on 1 payment
- John Glaspy Los Angeles, CA Named on 1 payment
- Mirelis Acosta Rio Piedras, PR Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.